FDA OKs First ‘Targeted Treatment’ for Rare DMD Mutation

The US Food and Drug Administration (FDA) has approved the antisense oligonucleotide casimersen (Amondys 45, Sarepta Therapeutics) injection for the treatment of patients with Duchenne muscular dystrophy (DMD) plus a rare DMD mutation, the agency has announced.  This particular mutation of the DMD gene “is amenable to exon 45 skipping,” the FDA noted in a press release. It added that […]

Read more

Task Force Tackles FDA Lamotrigine Cardiac Risk Warning

A joint task force of the American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) has issued an advisory to address concerns arising from a Food and Drug Administration (FDA) warning of cardiac risk in patients taking the antiseizure drug lamotrigine. The task force is concerned that the FDA warning is based on data not yet widely available, and […]

Read more

Biden Administration Changes Vaccination Timeline

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last week, Anthony Fauci, MD, said that “virtually everybody and anybody in any category could start to get vaccinated” in April. But on Tuesday, the Biden administration changed the timeline for mass vaccinations to May, June, or July. At a CNN town hall in Wisconsin, moderator […]

Read more

Health insurance often skips coverage for sex-related prescriptions

This story is from Kaiser Health News For some older people, the joy of sex may be tempered by financial concerns: Can they afford the medications they need to improve their experience between the sheets? Medicare and many private insurers don’t cover drugs that are prescribed to treat problems people have engaging in sex. Recent developments, including the approval of […]

Read more